The Medicines and Health products Regulatory Agency has reported that two batches of Largactil 50mg/2ml solution for injection from Aventis Pharma Ltd (Sanofi) have now been recalled.
Sanofi has pulled back the product due to impurity which was suspected to have been caused by increased oxidation as a result of higher oxygen content in the headspace of the ampoules, the MHRA has said.
|Product||Batch Number||Expiry Date||Pack Size||First Distributed|
|Largactil 50mg/2ml solution for injection||A90142||05/2022||10 x 2ml ampoules||8th April 2020|
|A90143||05/2022||10 x 2ml ampoules||10th June 2020|
Healthcare professionals have been advised to stop supplying the batches immediately and quarantine all stock and return the same to their supplier.